Home / Centerstage / 2016 / september / Week 2 /
Abbott Laboratories agrees to sell its eye-surgery equipment business, known as Abbott Medical Optics, to Johnson & Johnson for $4.325 billion. This deal strengthens J&J's position in the cataract surgeries market, estimated at $8 billion and growing at a rate of approximately 5% annually. Abbott is divesting the business as part of its strategic focus on faster-growing device segments.
Thursday, 15 September, 2016